80 related articles for article (PubMed ID: 11224212)
1. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system.
Wolf ME; White FJ; Hu XT
Behav Pharmacol; 1993; 4(4):429-442. PubMed ID: 11224212
[TBL] [Abstract][Full Text] [Related]
2. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations.
Li Y; Hu XT; Berney TG; Vartanian AJ; Stine CD; Wolf ME; White FJ
Synapse; 1999 Dec; 34(3):169-80. PubMed ID: 10523754
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
Hong SK; Jung IS; Bang SA; Kim SE
Neurosci Lett; 2006 Dec; 409(3):220-3. PubMed ID: 17046158
[TBL] [Abstract][Full Text] [Related]
4. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
Jeziorski M; White FJ; Wolf ME
Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
[TBL] [Abstract][Full Text] [Related]
5. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine.
Wolf ME; White FJ; Hu XT
J Neurosci; 1994 Mar; 14(3 Pt 2):1735-45. PubMed ID: 8126567
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system.
White FJ; Hu XT; Zhang XF; Wolf ME
J Pharmacol Exp Ther; 1995 Apr; 273(1):445-54. PubMed ID: 7714800
[TBL] [Abstract][Full Text] [Related]
7. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.
Wolf ME; Xue CJ; White FJ; Dahlin SL
Brain Res; 1994 Dec; 666(2):223-31. PubMed ID: 7882032
[TBL] [Abstract][Full Text] [Related]
8. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
Giorgi O; Piras G; Lecca D; Corda MG
Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
[TBL] [Abstract][Full Text] [Related]
10. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
12. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
13. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
David HN; Ansseau M; Lemaire M; Abraini JH
Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
[TBL] [Abstract][Full Text] [Related]
14. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
15. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine.
Filip M; Frankowska M; Zaniewska M; Przegaliński E; Muller CE; Agnati L; Franco R; Roberts DC; Fuxe K
Brain Res; 2006 Mar; 1077(1):67-80. PubMed ID: 16516871
[TBL] [Abstract][Full Text] [Related]
16. [Alteration of neuronal activities following repeated administration of stimulants].
Amano T; Matsubayashi H; Sasa M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological reactivity to cocaine in adult rats undernourished at perinatal age: behavioral and neurochemical correlates.
Valdomero A; Isoardi NA; Orsingher OA; Cuadra GR
Neuropharmacology; 2005 Mar; 48(4):538-46. PubMed ID: 15755481
[TBL] [Abstract][Full Text] [Related]
18. MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation.
Carlezon WA; Mendrek A; Wise RA
Synapse; 1995 May; 20(1):1-9. PubMed ID: 7624823
[TBL] [Abstract][Full Text] [Related]
19. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA
Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893
[TBL] [Abstract][Full Text] [Related]
20. Cocaine-induced sex differences in D1 receptor activation and binding levels after acute cocaine administration.
Festa ED; Jenab S; Weiner J; Nazarian A; Niyomchai T; Russo SJ; Kemen LM; Akhavan A; Wu HB; Quinones-Jenab V
Brain Res Bull; 2006 Jan; 68(4):277-84. PubMed ID: 16377433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
